Literature DB >> 26435234

Stage-related results in treatment of hip osteonecrosis with core-decompression and autologous mesenchymal stem cells.

Pietro Persiani, Claudia De Cristo, Jole Graci, Giovanni Noia, Michele Gurzì, Ciro Villani.   

Abstract

Our aim is to analyse the clinical outcome of a series of patients affected by avascular necrosis of the femoral head and treated with core-decompression technique and autologous stromal cells of the bone marrow.We enrolled in our study 29 patients with 31 hips in total affected by avascular necrosis of the femoral head. The clinical and radiological outcome has been assessed through self-administered questionnaires (HHS, VAS and SF12) X-ray and Magnetic Resonance.Of all the examined hips, 25 showed a relief of the symptoms and a resolution of the osteonecrosis, 11 of these were at Stage I and 14 at Stage II. The progression of the disease occurred in 6 hips (2 Stage II, 2 Stage III and 2 Stage IV). Our results show a significant decrease in joint pain level and a success in avoiding or delaying the need of hip replacement in early stages of osteonecrosis.

Entities:  

Mesh:

Year:  2015        PMID: 26435234

Source DB:  PubMed          Journal:  Acta Orthop Belg        ISSN: 0001-6462            Impact factor:   0.500


  11 in total

1.  Core Decompression Augmented With Autologous Bone Marrow Aspiration Concentrate for Early Avascular Necrosis of the Femoral Head.

Authors:  Lucas Arbeloa-Gutierrez; Chase S Dean; Jorge Chahla; Cecilia Pascual-Garrido
Journal:  Arthrosc Tech       Date:  2016-06-13

2.  Regenerative therapies increase survivorship of avascular necrosis of the femoral head: a systematic review and meta-analysis.

Authors:  Luca Andriolo; Giulia Merli; Carlos Tobar; Sante Alessandro Altamura; Elizaveta Kon; Giuseppe Filardo
Journal:  Int Orthop       Date:  2018-02-06       Impact factor: 3.075

3.  Chinese Guideline for the Diagnosis and Treatment of Osteonecrosis of the Femoral Head in Adults.

Authors: 
Journal:  Orthop Surg       Date:  2017-02       Impact factor: 2.071

4.  [Impacting bone graft via surgical hip dislocation approach versus core decompression and bone graft for avascular necrosis of femoral head at ARCO stage ].

Authors:  Haizhong Sun; Biaofang Wei
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2019-05-15

Review 5.  Nontraumatic Osteonecrosis of the Femoral Head: Where Do We Stand Today?: A 5-Year Update.

Authors:  Michael A Mont; Hytham S Salem; Nicolas S Piuzzi; Stuart B Goodman; Lynne C Jones
Journal:  J Bone Joint Surg Am       Date:  2020-06-17       Impact factor: 6.558

6.  Efficacy of umbilical cord-derived mesenchymal stem cell-based therapy for osteonecrosis of the femoral head: A three-year follow-up study.

Authors:  Chun Chen; Zhiguo Qu; Xiaoguang Yin; Chunyu Shang; Qiang Ao; Yongquan Gu; Ying Liu
Journal:  Mol Med Rep       Date:  2016-09-16       Impact factor: 2.952

7.  Survival Analysis after Core Decompression in Association with Platelet-Rich Plasma, Mesenchymal Stem Cells, and Synthetic Bone Graft in Patients with Osteonecrosis of the Femoral Head.

Authors:  Riccardo D'Ambrosi; Elena Biancardi; Giulia Massari; Vincenza Ragone; Renato Mario Facchini
Journal:  Joints       Date:  2018-02-12

8.  A specific affinity cyclic peptide enhances the adhesion, expansion and proliferation of rat bone mesenchymal stem cells on β‑tricalcium phosphate scaffolds.

Authors:  Tiantong Sun; Zhentao Man; Changliang Peng; Guozong Wang; Shui Sun
Journal:  Mol Med Rep       Date:  2019-06-04       Impact factor: 2.952

Review 9.  Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults (2019 version).

Authors:  Dewei Zhao; Feng Zhang; Benjie Wang; Baoyi Liu; Lu Li; Shin-Yoon Kim; Stuart B Goodman; Philippe Hernigou; Quanjun Cui; William C Lineaweaver; Jiake Xu; Wolf R Drescher; Ling Qin
Journal:  J Orthop Translat       Date:  2020-01-06       Impact factor: 5.191

Review 10.  Efficacy and safety of stem cell therapy for the early-stage osteonecrosis of femoral head: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Lianghao Mao; Pan Jiang; Xuan Lei; Chenlie Ni; Yiming Zhang; Bing Zhang; Qiping Zheng; Dapeng Li
Journal:  Stem Cell Res Ther       Date:  2020-10-19       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.